Investments
158Portfolio Exits
29Funds
3
Want to inform investors similar to De Novo Ventures about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest De Novo Ventures News
Apr 20, 2023
BARCELONA, Spain--(BUSINESS WIRE)--Anaconda Biomed, a medical technology company developing next-generation thrombectomy systems, today announced the appointment of a new board chairperson, and the naming of a new chief medical officer. Anaconda named Richard Ferrari, the co-founder of De Novo Ventures, as chairperson. Ferrari has co-founded, led, and advised scores of medical device and biotechnology companies for more than two decades, raising some $1 billion in financing and participating in
De Novo Ventures Investments
158 Investments
De Novo Ventures has made 158 investments. Their latest investment was in Milo as part of their Series A on January 1, 2023.
De Novo Ventures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
1/11/2023 | Series A | Milo | $12M | Yes | 2 | |
7/28/2021 | Private Equity | Cormatrix Cardiovascular | No | 1 | ||
4/16/2020 | Series D | RefleXion | $100M | Yes | 10 | |
7/12/2019 | Series C - II | |||||
4/29/2019 | Series G |
Date | 1/11/2023 | 7/28/2021 | 4/16/2020 | 7/12/2019 | 4/29/2019 |
|---|---|---|---|---|---|
Round | Series A | Private Equity | Series D | Series C - II | Series G |
Company | Milo | Cormatrix Cardiovascular | RefleXion | ||
Amount | $12M | $100M | |||
New? | Yes | No | Yes | ||
Co-Investors | |||||
Sources | 2 | 1 | 10 |
De Novo Ventures Portfolio Exits
29 Portfolio Exits
De Novo Ventures has 29 portfolio exits. Their latest portfolio exit was SynergEyes on November 01, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
11/1/2022 | Acquired | 1 | |||
4/27/2022 | IPO | Public | 3 | ||
11/24/2021 | IPO | Public | 2 | ||
Date | 11/1/2022 | 4/27/2022 | 11/24/2021 | ||
|---|---|---|---|---|---|
Exit | Acquired | IPO | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | Public | |||
Sources | 1 | 3 | 2 |
De Novo Ventures Fund History
3 Fund Histories
De Novo Ventures has 3 funds, including De Novo Ventures III LP.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
8/23/2006 | De Novo Ventures III LP | Early-Stage Venture Capital | Closed | $300M | 1 |
3/15/2004 | De Novo Ventures II LP | ||||
12/31/2000 | De Novo Ventures LP |
Closing Date | 8/23/2006 | 3/15/2004 | 12/31/2000 |
|---|---|---|---|
Fund | De Novo Ventures III LP | De Novo Ventures II LP | De Novo Ventures LP |
Fund Type | Early-Stage Venture Capital | ||
Status | Closed | ||
Amount | $300M | ||
Sources | 1 |
De Novo Ventures Team
10 Team Members
De Novo Ventures has 10 team members, including current Founder, Managing Director, Richard Ferrari.
Name | Work History | Title | Status |
|---|---|---|---|
Richard Ferrari | Founder, Managing Director | Current | |
Name | Richard Ferrari | ||||
|---|---|---|---|---|---|
Work History | |||||
Title | Founder, Managing Director | ||||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
